Douglass Winthrop Advisors LLC Grows Stock Position in Synopsys, Inc. (NASDAQ:SNPS)

Douglass Winthrop Advisors LLC increased its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 10.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,494 shares of the semiconductor company's stock after acquiring an additional 1,103 shares during the quarter. Douglass Winthrop Advisors LLC's holdings in Synopsys were worth $5,579,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in SNPS. Caprock Group LLC raised its position in shares of Synopsys by 0.5% in the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company's stock worth $1,803,000 after acquiring an additional 20 shares in the last quarter. Compagnie Lombard Odier SCmA grew its stake in Synopsys by 1.1% in the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company's stock worth $898,000 after purchasing an additional 20 shares during the period. Edge Capital Group LLC grew its stake in Synopsys by 1.2% in the fourth quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company's stock worth $791,000 after purchasing an additional 20 shares during the period. Barden Capital Management Inc. raised its holdings in Synopsys by 1.1% in the fourth quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock worth $889,000 after purchasing an additional 20 shares in the last quarter. Finally, Resurgent Financial Advisors LLC lifted its position in Synopsys by 2.8% during the third quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company's stock valued at $410,000 after buying an additional 22 shares during the period. Institutional investors own 85.47% of the company's stock.

Remove Ads

Synopsys Trading Down 0.1 %

SNPS stock traded down $0.54 during midday trading on Tuesday, hitting $457.23. The company's stock had a trading volume of 758,960 shares, compared to its average volume of 1,020,532. The firm's 50-day moving average is $490.60 and its 200-day moving average is $506.31. Synopsys, Inc. has a 12 month low of $425.73 and a 12 month high of $624.80. The company has a market cap of $70.70 billion, a PE ratio of 31.49, a P/E/G ratio of 3.23 and a beta of 1.16.

Insider Activity

In related news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now owns 1,460 shares of the company's stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 47,909 shares of company stock valued at $22,794,835 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

SNPS has been the topic of a number of recent research reports. Piper Sandler reduced their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Morgan Stanley cut their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a report on Monday, February 24th. Redburn Atlantic began coverage on shares of Synopsys in a research note on Monday, January 13th. They set a "buy" rating and a $600.00 target price for the company. Robert W. Baird dropped their price target on Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a research report on Thursday, December 5th. Finally, Needham & Company LLC restated a "buy" rating and issued a $650.00 price target on shares of Synopsys in a research note on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, Synopsys currently has a consensus rating of "Moderate Buy" and an average price target of $638.58.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.